Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Richard

Warren

,

BSc, MBChB, MRCP, PhD

Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist
University of Manchester
Salford
,
United Kingdom
Councilor Since: January 1, 2011
IPC Councilor
Request an Update
Professor Richard Warren is a Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist. He graduated from Liverpool University with a first-class honors degree in Pharmacology and gained his Medical degree, with honors, one year later. He was awarded The J Hill Abram prize — the highest mark in Medicine and the Reginald Dora Goodrick prize — highest mark in Surgery. His work in dermatology has focused on: pharmacogenetics (forming the basis of his PhD thesis), the genetic susceptibility to psoriasis, and more recently, biological therapies and their use in the treatment of psoriasis. For his work into the pharmacogenetics of methotrexate, he has received national and international awards from the British Association of Dermatologists (BAD) and the American Academy of Dermatology. He is widely published in the field of Dermatology with numerous abstracts, papers, and book contributions including The Lancet, Nature Genetics, and The Journal of Investigative Dermatology. He is currently the EU Editor-in-Chief for the journal Dermatology and Therapy. He has been an invited plenary speaker at major national and international dermatology meetings and is Councilor with The International Psoriasis Council. He currently chairs the BAD guideline group for methotrexate and is a member of the BAD biologics committee and research subcommittee. In 2012, he was the expert panel member on the National Institute for Health and Clinical Excellence guideline group for psoriasis. He is co-leader of one of the two workstreams involved in the successful funding from the Medical Research Council stratified medicine grant (Value £7 million) — Psoriasis Stratification to Optimise Relevant Therapies (PSORT). He is the Chief Investigator on the largest psoriasis study currently running in the UK, known as SIGNATURE, investigating a new biological therapy for the treatment of severe psoriasis. He is the principal investigator at Salford Royal NHS Foundation Trust for BADBIR, a large-scale pharmacovigilance study, and he led the team to the award for the highest recruiting center in 2012. He co-established a clinic for patients with severe psoriasis and psoriatic arthritis in 2010 with Dr. Hector Chinoy, and the clinic has received wide acclaim and is used as a national exemplar.
Last Updated:
01/25/2022

Languages Spoken

English
Recent publications

Featured

Blog

Focus on Psoriasis: A Report from the 33rd Annual European Academy of Dermatology and Venereology (EADV) Congress.

The 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…

Read More

Blog

Focus on Psoriasis: A Report from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV).

Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…

Read More

Blog

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting.

The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…

Read More

PDF

Focus on Psoriasis: A Report from the 2023 American Academy of Dermatology (AAD) Annual Meeting.

The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023,…

View Report

Event

Symposium: Innovations in the Pathogenesis and Treatment of Psoriasis.

EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | BERLIN, GERMANY Wednesday, October 11 8:30 – 11:45 am…

October 11, 2023
Learn More or Register

Video

Deucravacitinib: Efficacy and Safety Results from the Phase 3 Trials.

In this Take Ten, Dr. Warren provides an update on the phase three trial results for the new oral selective tyrosine…

Watch Video

PDF

Focus on Psoriasis – A Report from the 2021 Hybrid Gene to Clinic Congress.

View Report

PDF

Focus on Psoriasis - A Report from the 2021 Virtual EADV Congress.

Thomas Sharnitz, MD, has written the report, summarizing the most important presentations with a focus on psoriasis…

View Report

PDF

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the…

View Report

PDF

Exome-wide Association Study Reveals Novel Psoriasis Susceptibility Locus at TNFSF15 and Rare Protective Alleles in…

View Report

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026